Safety and Efficacy of the C-117 Formula for Vulnerable Carotid Artery Plaques (Spchim): A Randomized Double-Blind Controlled Pilot Study

Table 6

Blood lipid levels of the two groups whose Lipitor medication time ⩾20% of the 6-month treatment.

	C-117 formula group (n=44)	Placebo group (n=42)	Z/T	P
Triglyceride (mmol/L)
Before treatment	1.33 ± 0.58	1.56 ± 0.90
After treatment	1.25 ± 0.53	1.27 ± 0.56	-0.430	0.966
Total cholesterol (mmol/L)
Before treatment	5.02 ± 0.94	5.01 ± 0.78
After treatment	4.62 ± 0.96	4.74 ± 0.85	-0.567	0.572
Low-density lipoprotein (mmol/L)
Before treatment	3.09 ± 0.81	3.13 ± 0.78
After treatment	2.86 ± 0.79	3.04 ± 0.72	-1.116	0.267

M, mean ± standard deviation. P is the P value of the FAS dataset;
P<0.05 vs. before treatment.